Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Vaxart Inc
(NQ:
VXRT
)
0.9300
+0.0600 (+6.90%)
Streaming Delayed Price
Updated: 12:05 PM EDT, Aug 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Vaxart Inc
< Previous
1
2
3
4
5
6
7
8
Next >
It’s Time to Start Thinking Seriously About Vaxart
September 22, 2021
While VXRT stock is risky due to underlying clinical challenges, the evolving nature of Covid-19 makes it worth consideration.
Via
InvestorPlace
Topics
Government
Exposures
COVID-19
Political
Vaxart Looks To Be On The Verge Of Breaking Out Of A Pattern
September 13, 2021
Vaxart Inc. (NASDAQ: VXRT) shares are trading lower Monday, possibly after retail traders were able to push the stock higher. The stock looks to be almost breaking out of a...
Via
Benzinga
Vaxart Stock Is One Vaccine Also-Ran Worth Another Look
September 08, 2021
The jury's out whether its oral Covid-19 vaccine will be successful, but VXRT stock may still be worth it as a speculative play.
Via
InvestorPlace
Exposures
COVID-19
Is Vaxart Stock Really Worth a Shot?
August 30, 2021
VXRT stock still has hope as Vaxart is developing modern rDNA vaccines in pill form (including a Covid-19 vaccine).
Via
InvestorPlace
Exposures
COVID-19
Longshot Covid Play Vaxart Stock Is Too Risky at These Prices
August 27, 2021
Vaxart got approval Aug. 2 for a Phase II trial for its oral Covid-19 vaccine. VXRT stock has gained since, but it's still too pricey.
Via
InvestorPlace
Exposures
COVID-19
Unusual Options Activity Insight: Vaxart
August 11, 2021
Vaxart (NASDAQ:VXRT) shares experienced unusual options ac...
Via
Benzinga
Unusual Options Activity Insight: Vaxart
August 10, 2021
Shares of Vaxart (NASDAQ:VXRT) saw some unusual options a...
Via
Benzinga
Vaxart Is Another Risky Biotech Stock to Avoid Right Now
August 17, 2021
VRXT stock is highly overvalued. Investors are holding out for its Covid-19 vaccine, but it may not be approved in time to boost shares.
Via
InvestorPlace
Exposures
COVID-19
The Delta Variant Is a Shot in the Arm for Vaxart’s Pill Vaccine
August 10, 2021
With many unvaccinated and the Delta variant a growing danger, VXRT stock has a good chance to increase in value in the coming future.
Via
InvestorPlace
Exposures
COVID-19
Vaxart Stock Probably Isn’t Worth the Risk as It Pushes Higher
August 10, 2021
Vaxart’s oral recombinant vaccines are an interesting approach. Whether they do anything for VXRT stock remains to be seen.
Via
InvestorPlace
Why Shares of Vaxart Are Soaring Today
August 09, 2021
Some encouraging news for this troubled biotech.
Via
The Motley Fool
Exposures
COVID-19
28 Stocks Moving in Friday's Pre-Market Session
August 06, 2021
Gainers Sphere 3D Corp. (NASDAQ: ANY) shares rose 35.4% to $4.66 in pre-market trading after the company reported an Agreement to acquire exclusive rights for assignment of...
Via
Benzinga
The Bull Thesis for VXRT Stock is Questionable at Best
August 03, 2021
Vaxart is far too risky for far too little
Via
InvestorPlace
California and NYC Order Mandatory COVID-19 Testing Among Municipal Workers
August 03, 2021
Via
FinancialNewsMedia
Exposures
COVID-19
Why Vaxart's Stock Price Is Being Compressed In A Pennant Pattern And Looks Ready To Break Soon
August 02, 2021
Vaxart Inc. (NASDAQ: VXRT) shares pushed higher Monday after the company made an announcement stating the U.S. Food and Drug Administration cleared its Investigational New Drug...
Via
Benzinga
VXRT Stock: The Big FDA News Sending Vaxart Shooting Higher Today
August 02, 2021
VXRT stock is bulking up today. The company is getting approval from the FDA regarding its Covid vaccine, allowing for further research.
Via
InvestorPlace
Exposures
COVID-19
Product Safety
Vaxart Stock Is Trading Higher As FDA Clears Mid-Stage Trial For S-Only Oral COVID-19 Vaccine Candidate
August 02, 2021
The FDA has signed off Vaxart Inc's (NASDAQ: VXRT) Investigational New Drug application for an S-only oral tablet SARS-CoV-2 vaccine candidate. "This is...
Via
Benzinga
Exposures
COVID-19
Product Safety
Why Vaxart's Stock Is Trading Higher Today
August 02, 2021
Vaxart Inc (NASDAQ: VXRT) is trading higher Monday morning after the company announced the U.S. Food and Drug Administration cleared its Investigational New Drug...
Via
Benzinga
Understanding Vaxart's Unusual Options Activity
July 29, 2021
Shares of Vaxart (NASDAQ:VXRT) saw some unusual options activity on Thursday. Following the unusual option alert, the stock price moved down to $7.91. Sentiment: BEARISH Option...
Via
Benzinga
Vaxart Stock Shoots Higher After Its Oral Vaccine Boosts Immune Response In Previously Vaccinated Subject
July 29, 2021
Vaxart Inc's (NASDAQ: VXRT) has disclosed data from a 12-subject Phase 1b blinded study evaluating the ability of its oral norovirus vaccine to boost...
Via
Benzinga
Why Vaxart's Stock Is Surging Higher Today
July 29, 2021
Vaxart Inc (NASDAQ: VXRT) is trading higher Thursday morning after the company announced that it has shown, for the first time in clinical trials, that its oral tablet...
Via
Benzinga
Vaxart Stock Has Built-In Value Well Beyond Its Covid Pill
July 26, 2021
You can buy VXRT stock for the company's tablet-based Covid-19 vaccine, and hold it for Vaxart's other clinical breakthroughs.
Via
InvestorPlace
Exposures
COVID-19
Vaxart Is Gaining Relevance, But Its Future Is Still Uncertain
July 22, 2021
Vaxart may have a second chance at prominence with its Covid-19 vaccine pill. But VXRT stock is still a largely speculative buy.
Via
InvestorPlace
Exposures
COVID-19
Why Shares of Vaxart Jumped 31.2% in the First Half of 2021
July 19, 2021
The first half has been a cycle of hope and disappointment for shareholders.
Via
The Motley Fool
Why Coronavirus Stocks Are Zooming Higher Today
July 19, 2021
The surge in cases and deaths could significantly ramp up demand for these companies' existing and pipeline products.
Via
The Motley Fool
Topics
Death
Exposures
COVID-19
Death
3 Small-Cap Stocks With 158% to 329% Upside, According to Wall Street
July 15, 2021
Analysts' high-water price targets imply some serious gains for these companies.
Via
The Motley Fool
Topics
Economy
Exposures
COVID-19
Economy
Don’t Count on a Covid-19 Boost for Vaxart
July 14, 2021
VXRT stock remains a speculative bet as the company's chance to develop an oral Covid-19 vaccine grows slimmer every day.
Via
InvestorPlace
Exposures
COVID-19
New Developments Have Made Vaxart Stock So Much More Attractive
July 13, 2021
Vaxart recently made a licensing deal, and two research firms issued upbeat assessments of the company, making me more upbeat on VXRT stock.
Via
InvestorPlace
Exposures
COVID-19
Watch Out for a Selloff in Vaxart Stock
July 09, 2021
VXRT stock's price may drop as their oral inoculation waits in the wings while other vaccine manufacturers take over the market.
Via
InvestorPlace
Exposures
COVID-19
Vaxart Inks Antiviral Asset Licensing Pact With Altesa Biosciences
July 07, 2021
Vaxart Inc (NASDAQ: VXRT) has granted Altesa Biosciences Inc an exclusive worldwide license to develop and commercialize Vaxart's patented...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.